Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PYXS | Common Stock | Award | $0 | +210K | +40.3% | $0.00 | 730K | Mar 24, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PYXS | Stock Option (Right to buy) | Disposed to Issuer | -157K | -100% | 0 | Mar 24, 2023 | Common Stock | 157K | $8.71 | Direct | F2, F3 | ||
transaction | PYXS | Stock Option (Right to buy) | Disposed to Issuer | -17.5K | -100% | 0 | Mar 24, 2023 | Common Stock | 17.5K | $8.71 | Direct | F2, F4 | ||
transaction | PYXS | Stock Option (Right to buy) | Award | +157K | 157K | Mar 24, 2023 | Common Stock | 157K | $2.21 | Direct | F2, F3 | |||
transaction | PYXS | Stock Option (Right to buy) | Award | +17.5K | 17.5K | Mar 24, 2023 | Common Stock | 17.5K | $2.21 | Direct | F2, F4 |
Id | Content |
---|---|
F1 | Represents restricted stock units that vest 25% on March 24, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |
F2 | In accordance with the terms of the Pyxis Oncology, Inc. 2019 Equity and Incentive Plan (the "Plan"), the Board of Directors of Pyxis Oncology, Inc. approved a stock option repricing pursuant to which option awards granted under the Plan were amended to reduce the exercise price to $2.21 per share, the closing stock price on the date of Board approval. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. |
F3 | These stock options vested 25% on the first anniversary of the September 13, 2021 grant date, and then vests in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |
F4 | These stock options vested 25% on the first anniversary of the closing of the Issuer's initial public offering, and then vests in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |